Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
imatinib (gleevec) (3 trials)
Acute Lung Injury (Phase 1)
Lung Injury (Phase 1)
Respiratory Distress Syndrome (Phase 1)
Wounds and Injuries (Phase 1)
Trials (3 total)
Trial APIs (1 total)